Hani Gabra

61.4k total citations · 2 hit papers
174 papers, 7.4k citations indexed

About

Hani Gabra is a scholar working on Reproductive Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Hani Gabra has authored 174 papers receiving a total of 7.4k indexed citations (citations by other indexed papers that have themselves been cited), including 93 papers in Reproductive Medicine, 64 papers in Oncology and 61 papers in Molecular Biology. Recurrent topics in Hani Gabra's work include Ovarian cancer diagnosis and treatment (88 papers), Endometrial and Cervical Cancer Treatments (22 papers) and Cancer, Lipids, and Metabolism (15 papers). Hani Gabra is often cited by papers focused on Ovarian cancer diagnosis and treatment (88 papers), Endometrial and Cervical Cancer Treatments (22 papers) and Cancer, Lipids, and Metabolism (15 papers). Hani Gabra collaborates with scholars based in United Kingdom, United States and Germany. Hani Gabra's co-authors include John F. Smyth, Maria Kyrgiou, Marc J. Gunter, Ilkka Kalliala, Konstantinos K. Tsilidis, Pierre L. Martin‐Hirsch, Evangelos Paraskevaidis, Georgios Markozannes, Euan A. Stronach and Sarah P. Blagden and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Nature Communications.

In The Last Decade

Hani Gabra

173 papers receiving 7.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Adiposity and cancer at major anatomical sites: umbrella review of the literature

2017 543 citations Hani Gabra et al. profile →
Risk factors for endometrial cancer: An umbrella review of the literature

2018 358 citations Hani Gabra et al. profile →

Peers

Countries citing papers authored by Hani Gabra

Since Specialization

Citations

This map shows the geographic impact of Hani Gabra's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hani Gabra with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hani Gabra more than expected).

Fields of papers citing papers by Hani Gabra

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hani Gabra. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hani Gabra. The network helps show where Hani Gabra may publish in the future.

Co-authorship network of co-authors of Hani Gabra

This figure shows the co-authorship network connecting the top 25 collaborators of Hani Gabra. A scholar is included among the top collaborators of Hani Gabra based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hani Gabra. Hani Gabra is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A novel application of calcium electroporation to cutaneous manifestations of gynaecological cancer 2021 ·European Journal of Gynaecological Oncology ·(unknown), Srdjan Saso, (unknown), Nicolas Galazis, David L. Phelps, Benjamin P. Jones, (unknown), (unknown), (unknown), Hani Gabra, Christina Fotopoulou, Sadaf Ghaem‐Maghami, James R. Smith	8
2	A Phase Ib Open-Label, Dose-Escalation Study of NUC-1031 in Combination with Carboplatin for Recurrent Ovarian Cancer 2021 ·Clinical Cancer Research ·Farasat Kazmi, Shibani Nicum, René L. Roux, Laura Spiers, (unknown), (unknown), Hani Gabra, Essam Ghazaly, Nigel McCracken, David J. Harrison, Sarah P. Blagden	4
3	Rational treatment of chemotherapy-induced peripheral neuropathy with capsaicin 8% patch: from pain relief towards disease modification 2019 ·SHILAP Revista de lepidopterología ·(unknown), (unknown), (unknown), Kuban D. Naidoo, Y. Yiangou, Philippe Donatien, Hani Gabra, Harpreet Wasan, Laura Kenny, Amin Rahemtulla, Peter Misra	1
4	A mathematical-descriptor of tumor-mesoscopic-structure from computed-tomography images annotates prognostic- and molecular-phenotypes of epithelial ovarian cancer 2019 ·Nature Communications ·Haonan Lu, Mubarik Arshad, Andrew Thornton, Giacomo Avesani, Paula Cunnea, Edward Curry, Fahdi Kanavati, Huan-Chang Liang, Katherine Nixon, Sophie Williams, Mohd Ali Hassan, David D.L. Bowtell, Hani Gabra, Christina Fotopoulou, Andrea Rockall, Eric O. Aboagye	128
5	Diffusion-weighted MRI in Advanced Epithelial Ovarian Cancer: Apparent Diffusion Coefficient as a Response Marker 2019 ·Radiology ·Jessica Winfield, (unknown), David Dolling, Marcia Hall, Susan Freeman, James D. Brenton, (unknown), Erika Pace, Andrew N. Priest, Rebecca Quest, N. Jane Taylor, Hani Gabra, (unknown), David J. Collins, Susana Banerjee, Emma Hall, Nandita M. deSouza	24
6	Phase IB Dose Escalation and Expansion Study of AKT Inhibitor Afuresertib with Carboplatin and Paclitaxel in Recurrent Platinum-resistant Ovarian Cancer 2018 ·Clinical Cancer Research ·Sarah P. Blagden, Anne Hamilton, Linda Mileshkin, Shirley Wong, Agnieszka Michael, Marcia Hall, Jeffrey C. Goh, Alla Lisyanskaya, Michelle DeSilvio, Eleni Frangou, Euan A. Stronach, Prashanth Gopalakrishna, Tarek Meniawy, Hani Gabra	50
7	Biomarker Assessment of HR Deficiency, Tumor BRCA1/2 Mutations, and CCNE1 Copy Number in Ovarian Cancer: Associations with Clinical Outcome Following Platinum Monotherapy 2018 ·Molecular Cancer Research ·Euan A. Stronach, James Paul, Kirsten M. Timms, Elisha Hughes, Krystal Brown, Christopher Neff, M. D. Perry, Alexander Gutin, Mona El‐Bahrawy, Jennifer H. Steel, Xinxue Liu, Liz-Anne Lewsley, Nadeem Siddiqui, Hani Gabra, Jerry S. Lanchbury, Robert Brown	81
8	Dynamics of the Intratumoral Immune Response during Progression of High-Grade Serous Ovarian Cancer 2018 ·Neoplasia ·(unknown), Stephan Wienert, Dan Cacsire Castillo‐Tong, Caroline Kreuzinger, Ignace Vergote, (unknown), Hani Gabra, Charlie Gourley, Ram Ganapathi, (unknown), Jan Budczies, Jalid Sehouli, Ilary Ruscito, Carsten Denkert, Hagen Kulbe, Wolfgang Schmitt, Korinna Jöhrens, Elena Ioana Braicu, Silvia Darb‐Esfahani	20
9	Oxidative metabolism drives inflammation-induced platinum resistance in human ovarian cancer 2016 ·Cell Death and Differentiation ·Danilo Swann Matassa, Maria Rosaria Amoroso, Haonan Lu, Rosario Avolio, (unknown), Claudio Procaccini, Deriggio Faicchia, Francesca Maddalena, Vittorio Simeon, Ilenia Agliarulo, (unknown), Carmela Mazzoccoli, Chiara Recchi, Euan A. Stronach, Gianni Marone, Hani Gabra, Giuseppe Matarese, Matteo Landriscina, Franca Esposito	143
10	The molecular genetics of hereditary and sporadic ovarian cancer: implications for the future 2014 ·British Medical Bulletin ·Maise Al Bakir, Hani Gabra	18
11	A randomised, phase II trial of the DNA-hypomethylating agent 5-aza-2′-deoxycytidine (decitabine) in combination with carboplatin vs carboplatin alone in patients with recurrent, partially platinum-sensitive ovarian cancer 2014 ·British Journal of Cancer ·Rosalind Glasspool, Robert Brown, Martin Gore, Gordon Rustin, Iain A. McNeish, Richard H. Wilson, (unknown), James Paul, Melanie Mackean, Geoff Hall, Hani Gabra, Sarah Halford, Julie Walker, Kim Appleton, (unknown), Stan B. Kaye	84
12	Wild-type and mutant p53 mediate cisplatin resistance through interaction and inhibition of active caspase-9 2013 ·Cell Cycle ·(unknown), (unknown), David P. Lane, Sai Mun Leong, Jacqueline E. Noll, Paul M. Neilsen, (unknown), Hani Gabra, Tit Meng Lim	51
13	The OPCML Tumor Suppressor Functions as a Cell Surface Repressor–Adaptor, Negatively Regulating Receptor Tyrosine Kinases in Epithelial Ovarian Cancer 2012 ·Cancer Discovery ·Arthur B. McKie, Sebastian Vaughan, (unknown), Imoh S. Okon, (unknown), (unknown), Mark I. Greene, Qiang Wang, Roshan Agarwal, Dmitry Shaposhnikov, Joshua L. C. Wong, (unknown), Szymon Janczar, Mona El‐Bahrawy, Eric W.‐F. Lam, Naomi E. Chayen, Hani Gabra	41
14	Randomized Phase II Placebo-Controlled Trial of Maintenance Therapy Using the Oral Triple Angiokinase Inhibitor BIBF 1120 After Chemotherapy for Relapsed Ovarian Cancer 2011 ·Journal of Clinical Oncology ·Jonathan A. Ledermann, Allan Hackshaw, (unknown), Gordon C. Jayson, Hani Gabra, Iain A. McNeish, Helena Earl, Timothy Perren, Martin Gore, Mojca Persic, Malcolm Adams, Lindsay E. James, Graham Temple, Michael Merger, Gordon Rustin	164
15	HDAC4-Regulated STAT1 Activation Mediates Platinum Resistance in Ovarian Cancer 2011 ·Cancer Research ·Euan A. Stronach, (unknown), Nona Rama, Christoph Datler, James B. Studd, Roshan Agarwal, Tankut G. Güney, Charlie Gourley, Bryan T. Hennessy, Gordon B. Mills, Antonello Mai, Robert Brown, Roberto Dina, Hani Gabra	148
16	WWOX Gene Expression Abolishes Ovarian Cancer Tumorigenicity In vivo and Decreases Attachment to Fibronectin via Integrin α3 2009 ·Cancer Research ·Charlie Gourley, Adam J.W. Paige, Karen J. Taylor, (unknown), (unknown), Jieqing Zhang, Mingjun Sun, Szymon Janczar, David J. Harrison, Morwenna Muir, John F. Smyth, Hani Gabra	84
17	An Unusual Case of Sex Cord Tumor With Annular Tubules With Malignant Transformation in a Patient With Peutz-Jeghers Syndrome 2009 ·International Journal of Gynecological Pathology ·Douglas C. Barker, Rohini Sharma, Angus McIndoe, Ed Blair, Marcia Hall, Hani Gabra, Mona El‐Bahrawy	18
18	Identification of functional modulators of platinum resistance using isogenically matched ovarian cancer cell line models. 2008 ·Cancer Research ·Euan A. Stronach, Nona Rama, Hani Gabra	2
19	On behalf of the Scottish Gynaecological Cancer Trials Group. Phase III Randomized Trial of Docetaxel?Carboplatin Versus Paclitaxel?Carboplatin as First-line Chemotherapy for Ovarian Carcinoma 2004 ·JNCI Journal of the National Cancer Institute ·(unknown), Gordon C. Jayson, Amanda Gordon, Hani Gabra, RE Coleman, (unknown), David E. Parkin, James Paul, (unknown), (unknown)	100
20	Malignant mixed mesodermal tumours 2002 ·European Journal of Cancer ·Charlie Gourley, A. Al‐Nafussi, Mohammad A. Abdulkader, John F. Smyth, Hani Gabra	10

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact